Skip to content

Author

D. Malathi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation

A substantial proportion of patients with hypercholesterolaemia, particularly those with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolaemia (HeFH), do not achieve recommended LDL-cholesterol (LDL-C) targets despite statins, ezetimibe, and injectable PCSK9 inhibitors. The paren...

D. Malathi, Kumaravel Janakiraman, Sathiya Vinotha Ariyur Thangavelu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.